- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04904380
Impact of New Tools of Simulation-enhanced Peer Learning on Neonatal and Maternal Mortality (Sim-II)
Impact of Simulation-enhanced Peer Learning With Novel Tools on Maternal and Newborn Mortality Plus Knowledge, Skills Retention and Decision Making by Front-line Health Workers in Southwestern Uganda
In the vast majority of developing nations, frontline birth attendants are often the only care providers responsible for newborn care including newborn resuscitation, thermal care, feeding and administration of medications. These midwives need knowledge and skills to provide all these newborn clinical care needs. However, frontline birth attendants in these circumstances are seldom exposed to the training and decision support tools that would empower them to holistically assess, decide and manage newborn babies in their care. Current training opportunities are fragmented and need to be administered as a comprehensive package.
A combination approach to training, skills retention, and the use of decision support tools such as Protecting Infants Remotely by SMS (PRISMS) and Augmented Infant Resuscitator (AIR) may provide a comprehensive package for the acquisition and retention of knowledge and skills on newborn care and empower birth attendants to provide effective, timely interventions.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators will implement the Sim for Life Impart, Retain, Empower and Monitor (IREM) module at the University of Jos teaching Hospital and 4 high volume health facilities in Tanzania in addition to the Uganda sites. We propose to implement the program with all its components for each of the partner institutions.
The Sim for Life IREM module combines four strategies: Impart skills using Helping Babies Survive (HBS)/Helping Mothers Survive (HMS) courses, Retain skills (Simulation), Empower birth attendants (PRISMS and AIR) and Monitor progress objectively. The simulation sessions for health facilities will be conducted using the peer to peer learning methodology which equips participants with the skills to facilitate simulation scenarios in their health facilities. The scenarios will be provided by the Sim for life team. The topics for the scenarios will be based on common maternal and newborn illnesses like post-partum hemorrhage, pre-eclampsia, birth asphyxia, neonatal sepsis and prematurity.
All health facilities in this study will require smart phones for the PRISMS application, resuscitation practice tables, source of electricity to charge a phone, practice manikins / associated practice supplies and peer learning cards.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Data Santorino, MD
- Phone Number: 0774500571
- Email: sdata@must.ac.ug
Study Contact Backup
- Name: Francis Bajunirwe, MD, PhD
- Phone Number: 0772 576 396
- Email: fbaj@must.ac.ug
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Newborns babies
- Mothers delivering at participating health facilities
- Health workers providing maternal and newborn care services at participating health facilities
Exclusion Criteria:
- Health care workers not providing maternal and newborn care services
- Male patients
- Non pregnant female patients seeking care at participating health facilities
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
HMS, HBS and peer learning in combination with AIR and PRISMS
|
HMS, HBS and peer learning in combination with AIR and PRISMS
Other Names:
|
|
Active Comparator: Comparison arm
HMS, HBS and peer learning in combination with PRISMS but no AIR
|
HMS, HBS and peer learning in combination with AIR and PRISMS
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neonatal mortality
Time Frame: Neonatal mortality at 6 months
|
Neonatal mortality
|
Neonatal mortality at 6 months
|
|
Neonatal mortality
Time Frame: Neonatal mortality at 18 months
|
Neonatal mortality
|
Neonatal mortality at 18 months
|
|
Maternal mortality
Time Frame: Maternal mortality at 6 months
|
Maternal mortality
|
Maternal mortality at 6 months
|
|
Maternal mortality
Time Frame: Maternal mortality at 18 months
|
Maternal mortality
|
Maternal mortality at 18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of stay in hospital
Time Frame: 18 months
|
Number of days as length of stay
|
18 months
|
|
Completeness of newborn assessment
Time Frame: At admission
|
Completeness of newborn assessment checklist
|
At admission
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Data Santorino, MD, Mbarara University of Science and Technology
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020/MUST-5/SIM-II
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.